Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Prophylactic antibiotic regimens in tumour surgery (PARITY): a pilot multicentre randomised controlled trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Muscle as an osteoinductive niche for local bone formation with the use of a biphasic calcium sulphate/hydroxyapatite biomaterial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pharmacokinetics of gentamicin eluted from a regenerating bone graft substitute: In vitro and clinical release studies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • PARITY Investigators (Petersen MM, Hettwer W, Grum Schwensen TA)
Vis graf over relationer

OBJECTIVE: Clinical studies of patients with bone sarcomas have been challenged by insufficient numbers at individual centres to draw valid conclusions. Our objective was to assess the feasibility of conducting a definitive multi-centre randomised controlled trial (RCT) to determine whether a five-day regimen of post-operative antibiotics, in comparison to a 24-hour regimen, decreases surgical site infections in patients undergoing endoprosthetic reconstruction for lower extremity primary bone tumours.

METHODS: We performed a pilot international multi-centre RCT. We used central randomisation to conceal treatment allocation and sham antibiotics to blind participants, surgeons, and data collectors. We determined feasibility by measuring patient enrolment, completeness of follow-up, and protocol deviations for the antibiotic regimens.

RESULTS: We screened 96 patients and enrolled 60 participants (44 men and 16 women) across 21 sites from four countries over 24 months (mean 2.13 participants per site per year, standard deviation 2.14). One participant was lost to follow-up and one withdrew consent. Complete data were obtained for 98% of eligible patients at two weeks, 83% at six months, and 73% at one year (the remainder with partial data or pending queries). In total, 18 participants missed at least one dose of antibiotics or placebo post-operatively, but 93% of all post-operative doses were administered per protocol.

CONCLUSIONS: It is feasible to conduct a definitive multi-centre RCT of post-operative antibiotic regimens in patients with bone sarcomas, but further expansion of our collaborative network will be critical. We have demonstrated an ability to coordinate in multiple countries, enrol participants, maintain protocol adherence, and minimise losses to follow-up. Cite this article: Bone Joint Res;4:154-162.

OriginalsprogEngelsk
TidsskriftBone & joint research
Vol/bind4
Udgave nummer9
Sider (fra-til)154-62
Antal sider9
DOI
StatusUdgivet - sep. 2015

ID: 46229066